Children's Oncology Group: Leukemia trials

The registry lists 140 Leukemia studies with Children's Oncology Group as lead sponsor. 2 are open to participants now and 28 have results posted.

Phase 1 15Phase 2 22Phase 3 26No phase 82(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
• Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00437060
• Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionCompletedNCT00268528
• Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic LeukemiaCompletedNCT00085176
• Temozolomide in Treating Young Patients With Refractory or Recurrent LeukemiaCompletedNCT00083070Phase 1
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationCompletedNCT00080873Not applicable
• Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyCompletedNCT00070174Phase 2
• Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic LeukemiaCompletedNCT00056069Not applicable
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00028899Phase 1
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
• Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaCompletedNCT00021242Phase 2
• Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid LeukemiaCompletedNCT00009698Phase 1
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaCompletedNCT00006462Phase 2
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00005977Phase 3
• Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005945Phase 3
• Quality of Life in Children Treated for CancerCompletedNCT00005881
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005603Phase 3
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00005596Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005585Phase 3
• STI571 in Treating Patients With Recurrent LeukemiaCompletedNCT00004932Phase 1
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004056Phase 1
• Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic LeukemiaCompletedNCT00003933Not applicable
• Genetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaCompletedNCT00003793
• Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00003790
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
• Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00003735Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeCompletedNCT00003593Phase 3
• Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic LeukemiaCompletedNCT00003291
• Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00003217Phase 1
• Chemotherapy in Treating Children With Recurrent Acute Myeloid LeukemiaCompletedNCT00003178Phase 2
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00002816Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaCompletedNCT00002812Phase 3
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00002785Phase 2
• TITLE:Less Intensive Therapy for Children With Non-Hodgkin's LymphomaCompletedNCT00002757Phase 3
• Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002756Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002744Phase 3
• Interferon Alfa in Treating Children With HIV-Related CancerCompletedNCT00002621Phase 2
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT00002485